PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes
2024-03-28
(Press-News.org)

(MEMPHIS, Tenn. – March 28, 2024) Resistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Children’s Research Hospital scientists demonstrated that in bilateral Wilms tumor (cancer in both kidneys) chemotherapy resistance can point toward a more favorable histology and an ultimatelygood outcome. The study revealed that tumors that do not respond to neoadjuvant, or tumor-shrinking, chemotherapy are predominantly composed of stromal cells with a well-circumscribed growth pattern. This suggests halting further rounds of ineffective chemotherapy or performing unnecessary biopsies in favor of kidney-sparing surgery may be most beneficial. The findings were published today in the Journal of the National Cancer Institute. 

 

Wilms tumor, or nephroblastoma, is a predominantly pediatric kidney cancer that affects approximately 1 in 10,000 children worldwide. The disease usually presents as unilateral, meaning only one kidney is affected. In the U.S., treatment typically includes a radical nephrectomy, the removal of the kidney, and has a positive overall cure rate of 85%. About 5-10% of Wilms tumor cases present bilaterally, meaning the cancer is present in both kidneys. Bilateral nephrectomy in these cases is not appropriate as it would sacrifice kidney function, so neoadjuvant chemotherapy is the preferred treatment. While the response to neoadjuvant chemotherapy is generally positive in Wilms tumor, resistance can occur. However, these chemotherapy-resistant tumors can still have a favorable outcome.   

 

Joining the dots of drug resistance 

 

“When children have tumors in both kidneys, it’s a very different approach than unilateral disease. We have to start with chemotherapy in an effort to shrink the tumors and make them more amenable to kidney-sparing surgery, preferably on both sides,” said Andrew Davidoff, MD, St. Jude Department of Surgery chair, “But sometimes the tumors actually grow while receiving chemotherapy, and initially, it seemed like that would be a bad thing.” 

 

Despite the rarity of bilateral Wilms tumor, the St. Jude researchers were advantageously positioned to include 68 patients in a study of the correlations between tumor histology, chemotherapy resistance and patient outcomes. In particular, the researchers explored whether such drug-resistant tumors were composed predominantly of stromal cells, which form the supportive tissue of the kidney, rather than epithelial- or blastemal-predominant. 

 

The bigger they are, the harder they fall 

 

The researchers found that Wilms tumors composed of predominantly stromal cells tended to have favorable outcomes despite being resistant to chemotherapy. While stromal-predominant tumors continued growing under chemotherapy, the survival rate for these patients in the study was almost 94%. 

 

“Wilms tumor with unfavorable outcomes actually do generally respond well, at least initially, to the chemotherapy,” said Davidoff. “Whereas, at the other end of the spectrum, we have this extremely favorable type, this stromal-predominant tumor, that has typically good outcomes despite not responding very well to the chemotherapy.” 

 

The research has implications for treating bilateral Wilms tumor. Rather than continuing chemotherapy or performing a biopsy after resistance to initial chemotherapy, physicians should immediately perform kidney-sparing surgery.  

 

“The take-home message is: Don’t assume bad things if the tumor is growing during chemotherapy,” Davidoff concluded. 

 

Authors and funding 

 

The study’s first author is Colton Duncan, St. Jude; The study’s other authors are Suraj Sarvode Mothi, Teresa Santiago, Jordan Coggins, Dylan Graetz, Michael Bishop, Andrew Murphy, Daniel Green, and Matthew Krasin, St. Jude; and Elizabeth Mullen, Dana-Farber Cancer Institute/Boston Children’s Hospital. 

 

The study was supported by grants from the National Cancer Institute (P30 CA21765), and ALSAC, the fundraising and awareness organization of St. Jude. 

 

St. Jude Media Relations Contacts 

Chelsea Bryant  
Desk: (901) 595-0564 
Cell: (256) 244-2048 
chelsea.bryant@stjude.org 
media@stjude.org 

 

Rae Lyn Hartley 
Desk: (901) 595-4419 
Cell: (901) 686-2597 

raelyn.hartley@stjude.org 

media@stjude.org 

 

St. Jude Children’s Research Hospital  

St. Jude Children’s Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. 

END


[Attachments] See images for this press release:
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes

ELSE PRESS RELEASES FROM THIS DATE:

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

2024-03-28
HERSHEY, Pa. — Despite evidence that financial conflicts of interest may influence medical practice and research and may erode patient trust in medical professionals, these relationships remain pervasive. According to a new analysis of the Open Payments platform, a database that tracks payments between physicians and industry, a team led by a Penn State researcher found that doctors received approximately $12.1 billion from drug and device makers between 2013 and 2022.  Their findings published today (March 28) in JAMA. It’s one of the first studies to look at industry payments longitudinally and by specialty.  “Overall, ...

Discovery suggests new strategy against follicular lymphoma

2024-03-28
A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients. The study, published March 7 in Cancer Cell, showed that while mutations affecting a gene-regulating complex called BAF can put the cancer on a dangerous trajectory, they also make follicular lymphoma highly susceptible to experimental BAF-inhibitor drugs. “These encouraging findings could address critical and urgent challenges with this disease and have prompted us to begin planning clinical trials ...

Making the future too bright: how wishful thinking can point us in the wrong direction

2024-03-28
Everyone indulges in wishful thinking now and again. But when is that most likely to happen and when could it actually be harmful? A new study, led by the University of Amsterdam (UvA), demonstrates unequivocally that the greater the insecurity and anxiety of a situation, the more likely people are to become overly optimistic – even to the point where it can prevent us from taking essential action. The study's results have now been published in the journal American Economic Review. ‘People aren't purely truth-seekers - many beliefs are influenced by ...

Ochsner Health named to Newsweek’s America’s Greatest Workplaces 2024 for Job Starters

2024-03-28
NEW ORLEANS, La – Newsweek and Plant-A Insights Group have named Ochsner Health one of America's Greatest Workplaces for Job Starters in 2024. In a survey that included more than 75,000 young professionals and more than 540,000 company reviews, Ochsner earned 5 out of 5 stars. As the leading not-for-profit healthcare provider in the Gulf South, Ochsner is committed to championing career development among new professionals. "We at Ochsner are honored to receive recognition as a place of employment that offers ...

Three-year study of young stars with NASA’s Hubble enters new chapter

Three-year study of young stars with NASA’s Hubble enters new chapter
2024-03-28
In the largest and one of the most ambitious Hubble Space Telescope programs ever executed, a team of scientists and engineers collected information on almost 500 stars over a three-year period. This effort offers new insights into the stars' formation, evolution, and impact on their surroundings.  This comprehensive survey, called ULLYSES (Ultraviolet Legacy Library of Young Stars as Essential Standards), was completed in December 2023, and provides a rich spectroscopic dataset obtained in ultraviolet light that astronomers will be mining for decades to come. Because ultraviolet light can ...

North Carolina takes the lead in PFAs research with Collaboratory’s $3 million investment to expand the state’s research capacity

2024-03-28
WILMINGTON, N.C. (March 27, 2024) – The North Carolina Collaboratory – an organization dedicated to advancing scientific research for policymaking within North Carolina – today announced its partnership with Thermo Fisher Scientific to advance the State’s per- and polyfluoroalkyl substances (PFAS) research capabilities. Supported by critical appropriations from the North Carolina General Assembly (NCGA), the Collaboratory purchased five state-of-the-art mass spectrometers that continue to position North Carolina at the forefront of academic PFAS research nationally. This new partnership ...

Is it the school, or the students?

2024-03-28
Are schools that feature strong test scores highly effective, or do they mostly enroll students who are already well-prepared for success? A study co-authored by MIT scholars concludes that widely disseminated school quality ratings reflect the preparation and family background of their students as much or more than a school’s contribution to learning gains.  Indeed, the study finds that many schools that receive relatively low ratings perform better than these ratings would imply. Conventional ...

Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilis – findings from Denmark

Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilis – findings from Denmark
2024-03-28
In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the incidence of bacterial sexually transmitted infections (STI). According to the concept of sexual risk compensation, the start of PrEP treatment – a drug regimen which effectively prevents acquiring HIV – is associated with rises in STI as people feel protected against HIV while using it. However, von Schreeb et al. argue that available ...

Music: Song lyrics have become simpler and more repetitive since 1980

2024-03-28
We have been alerted to a potential error in some of the coding used by the authors in their analyses and are looking into this as a matter of urgency. The authors are confident that the main findings of the paper will remain unaltered, however some aspects may be affected and we have removed two sentences from the press release to reflect this. We will provide an update if there are further developments. We apologise for any inconvenience caused. The lyrics of English-language songs have become simpler and more repetitive over the past 40 years, according to a study published in Scientific Reports. Eva Zangerle and ...

Environment: More than half of Colorado River’s water used to irrigate crops

2024-03-28
Irrigation for agriculture uses more than half of the Colorado River’s total annual water flow, reports a paper published in Communications Earth & Environment. This finding is part of a new comprehensive assessment of how the Colorado River’s water is consumed — including both human usage and natural losses — and provides a more complete understanding of how the river’s water is used along its over 2,300 km (almost 1,500-mile) length. The Colorado River flows through the southwestern United States (including the Grand Canyon) and northwestern Mexico whilst supplying water to more than 40 million people and more than 2 million ...

LAST 30 PRESS RELEASES:

Rare, mysterious brain malformations in children linked to protein misfolding, study finds

Newly designed nanomaterial shows promise as antimicrobial agent

Scientists glue two proteins together, driving cancer cells to self-destruct

Intervention improves the healthcare response to domestic violence in low- and middle-income countries

State-wide center for quantum science: Karlsruhe Institute of Technology joins IQST as a new partner

Cellular traffic congestion in chronic diseases suggests new therapeutic targets

Cervical cancer mortality among US women younger than age 25

Fossil dung reveals clues to dinosaur success story

New research points way to more reliable brain studies

‘Alzheimer’s in dish’ model shows promise for accelerating drug discovery

Ultraprocessed food intake and psoriasis

Race and ethnicity, gender, and promotion of physicians in academic medicine

Testing and masking policies and hospital-onset respiratory viral infections

A matter of life and death

Huge cost savings from more efficient use of CDK4/6 inhibitors in metastatic breast cancer reported in SONIA study

What a gut fungus reveals about symbiosis and allergy

Insilico Medicine recognized by Endeavor Venture Group & Mount Sinai Health System with Showcase AI and Biotech Innovation Award

ESMO Asia Congress 2024: Event Announcement

The pathophysiological relationship and treatment progress of obstructive sleep apnea syndrome, obesity, and metabolic syndrome

“Genetic time machine” reveals complex chimpanzee cultures

Earning money while making the power grid more stable – energy consumers have a key role in supporting grid flexibility

No ‘one size fits all’ treatment for Type 1 Diabetes, study finds

New insights into low-temperature densification of ceria-based barrier layers for solid oxide cells

AI Safety Institute launched as Korea’s AI Research Hub

Air pollution linked to longer duration of long-COVID symptoms

Soccer heading damages brain regions affected in CTE

Autism and neural dynamic range: insights into slower, more detailed processing

AI can predict study results better than human experts

Brain stimulation effectiveness tied to learning ability, not age

Making a difference: Efficient water harvesting from air possible

[Press-News.org] Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes